(Q35866208)

10 August 2017

1 reference

title

Regression of left ventricular mass in systemic hypertension (English)

1 reference

10 August 2017

2

Brundage BH

1 reference

10 August 2017

D. Georgiou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1531790

5 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1531790

5 October 2022

publication date

1 January 1992

1 reference

10 August 2017

1 reference

10 August 2017

volume

15

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

5-16

1 reference

Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Precursors of sudden coronary death. Factors related to the incidence of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Left ventricular dynamics, energetics and coronary hemodynamics in hypertrophic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Elevated blood viscosity in patients with borderline essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

The effect of cardiac hypertrophy on the coronary collateral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

George Lyman Duff Memorial Lecture. Atherosclerosis complicating chronic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Effect of β-Receptor-Blocking Agents on Cardiovascular Structural Changes in Spontaneous and Noradrenaline-Induced Hypertension in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Clinical studies of drug reversal of hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Control of blood pressure and reduction of echocardiographically assessed left ventricular mass with one-daily timolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Left ventricular mass and exercise responses predict future blood pressure. The Muscatine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Dietary calcium induces regression of left ventricular hypertrophy in hypertensive non-insulin-dependent diabetic blacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Determination of left ventricular mass in dogs with rapid-acquisition cardiac computed tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Role of blood pressure in the development of congestive heart failure. The Framingham study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

False positive stress tests due to undetected left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Cardiac hypertrophy: useful adaptation or pathologic process?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Time-course of changes in cardiac hypertrophy and pressor mechanisms in two-kidney, one clip hypertensive rats during treatment with minoxidil, enalapril or after uninephrectomy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Pathophysiologic significance of “stress” or relative polycythemia in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The heart in hypertension: unresolved conceptual challenges. Special lecture

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The problem of obesity and hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Coronary hemodynamics in hypertensive heart disease: basic concepts and clinical consequences

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Prevention of coronary vasodilator reserve decrement in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Does norepinephrine play a central causative role in the process of cardiac hypertrophy?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

In vitro effects of catecholamines on protein synthesis in perfused rat heart*1

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Renin synthesis by canine aortic smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Implications of local angiotensin production in cardiovascular physiology and pharmacology

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The Renin-Angiotensin System and Sodium Homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Dietary salt intake. A determinant of cardiac involvement in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Left ventricular mass reduction during salt depletion in arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Regression of left ventricular hypertrophy in hypertension: comparative effects of three different drugs.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Cardiovascular effects of verapamil in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Regression of left ventricular hypertrophy from systemic hypertension by enalapril

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Effects of labetalol on left ventricular mass and function in hypertension — An assessment by serial echocardiography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Changes in ventricular septal thickness during diuretic therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Reversal of left ventricular hypertrophy by antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Effect of therapy on left ventricular function in hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Effect of blood pressure control on left ventricular hypertrophy in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The effects of antihypertensive therapy on left ventricular mass in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Cardiac hypertrophy in hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Echocardiographic studies of regression of left ventricular hypertrophy in hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Assessment of left-ventricular mass and its response to antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

BP as a Determinant of Cardiac Left Ventricular Muscle Mass

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

The prognostic value of ambulatory blood pressures.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Is left ventricular mass in apparently healthy, normotensive men correlated to maximal blood pressure during exercise?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Serial echocardiographic evaluation of left ventricular function in valvular disease, including reproducibility guidelines for serial studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Sources of variability in echocardiographic measurements

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Noninvasive quantification of left ventricular myocardial mass by gated proton nuclear magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Reproducibility of left ventricular myocardial volume and mass measurements by ultrafast computed tomography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Quantification of left ventricular myocardial mass in humans by nuclear magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Use of nuclear magnetic resonance imaging to show regression of hypertrophy with ramipril treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150104

7 January 2021

Identifiers

DOI

10.1002/CLC.4960150104

1 reference

10 August 2017

1 reference